Saving through partnership and innovation

Like many other large global pharmaceutical companies, this industry leader was faced with the challenge of decentralised translation spend and countless suppliers operating under different guidelines. 

This common scenario made it difficult to control global spend, leverage important translation assets, reduce cost, innovate and drive the necessary standardisation to ensure quality.

This company successfully consolidated its supplier base to two global vendors, yielding over $70 million in savings from RWS alone, through the deployment of workflow automation and innovation.

Download the case study to read the full story.